At Alexion, we are driven to develop and deliver life-transforming therapies for patients with devastating and severe rare diseases. Through our passion, we have become an acknowledged global leader in the diverse skills needed to move highly innovative orphan therapies rapidly and effectively from the laboratory to patients in need. We have significant experience in ultra-orphan drug discovery, regulatory affairs, and clinical trial design and recruitment. The company has a strong preclinical development infrastructure, including a proprietary antibody discovery platform, a robust translational medicine group and global experience in regulatory complexities involving therapies for paediatric and adult patients.
As Alexion continues to expand its pipeline and capabilities to serve more patients worldwide, our business development team evaluates partnering and investment opportunities with the potential to advance the development and delivery of breakthrough medical innovations. We invite companies and researchers who share our purpose and sense of urgency to contact us to discuss partnering opportunities by completing this form.